Small molecule activation with bimetallic systems: a landscape of cooperative reactivity

There is growing interest in the design of bimetallic cooperative complexes, which have emerged due to their potential for bond activation and catalysis, a feature widely exploited by nature in metalloenzymes, and also in the field of heterogeneous catalysis. Herein, we discuss the widespread opportunities derived from combining two metals in close proximity, ranging from systems containing multiple M-M bonds to others in which bimetallic cooperation occurs even in the absence of M⋯M interactions. The choice of metal pairs is crucial for the reactivity of the resulting complexes. In this context, we describe the prospects of combining not only transition metals but also those of the main group series, which offer additional avenues for cooperative pathways and reaction discovery. Emphasis is given to mechanisms by which bond activation occurs across bimetallic structures, which is ascribed to the precise synergy between the two metal atoms. The results discussed herein indicate a future landscape full of possibilities within our reach, where we anticipate that bimetallic synergism will have an important impact in the design of more efficient catalytic processes and the discovery of new catalytic transformations.

Activation of H-H, HO-H, C(sp2)-H, C(sp3)-H, and RO-H Bonds by Transition-Metal Frustrated Lewis Pairs Based on M/N (M = Rh, Ir) Couples

Reaction of the dimers [(Cp*MCl)₂(μ-Cl)₂] (Cp* = η⁵-C₅Me₅) with Ph₂PCH₂CH₂NC(NH(p-Tolyl))₂ (H₂L) in the presence of NaSbF₆ affords the chlorido complexes [Cp*MCl(κ²N,P-H₂L)][SbF₆] (M = Rh, 1; Ir, 2). Upon treatment with aqueous NaOH, solutions of 1 and 2 yield the corresponding complexes [Cp*M(κ³N,N′,P-HL)][SbF₆] (M = Rh, 3; Ir, 4) in which the ligand HL presents a fac κ³N,N′,P coordination mode. Treatment of THF solutions of complexes 3 and 4 with hydrogen gas, at room temperature, results in the formation of the metal hydrido-complexes [Cp*MH(κ²N,P-H₂L)][SbF₆] (M = Rh, 5; Ir, 6) in which the N(p-Tolyl) group has been protonated. Complexes 3 and 4 react with deuterated water in a reversible fashion resulting in the gradual deuteration of the Cp* group. Heating at 383 K THF/H₂O solutions of the complexes 3 and 4 affords the orthometalated complexes [Cp*M(κ³C,N,P-H₂L_-H)][SbF₆] [M = Rh, 7; Ir, 8, H₂L_-H = Ph₂PCH₂CH₂NC(NH(p-Tolyl))(NH(4-C₆H₃Me))], respectively. At 333 K, complexes 3 and 4 react in THF with methanol, primary alcohols, or 2-propanol giving the metal-hydrido complexes 5 and 6, respectively. The reaction involves the acceptorless dehydrogenation of the alcohols at a relatively low temperature, without the assistance of an external base. The new complexes have been characterized by the usual analytical and spectroscopic methods including the X-ray diffraction determination of the crystal structures of complexes 1–5, 7, and 8. Notably, the chlorido complexes 1 and 2 crystallize both as enantiopure conglomerates and as racemates. Reaction mechanisms are proposed based on stoichiometric reactions, nuclear magnetic resonance studies, and X-ray crystallography as well as density functional theory calculations.

In solution, masked transition-metal frustrated Lewis pairs (TMFLPs) give rise to the corresponding TMFLP species which activate dihydrogen, water, and alcohols following FLP reaction pathways. When D₂O or alcohols with deuterated OH groups were employed, H/D exchange at the Cp* ligand (involving C(sp³)−H activation) was observed. C(sp²)−H bond activation involving orthometalation of the p-Tolyl ring was also observed.

Potent cyclometallated Pd(II) antitumor complexes bearing α-amino acids: synthesis, structural characterization, DNA/BSA binding, cytotoxicity and molecular dynamics simulation

A rational approach was adopted to design high-potential metal-based antitumor agents. A series of organometallic Pd(ii) complexes with a general formula of [Pd{κ2(C,C)-[(C6H4-2)PPh2]CH(CO)C6H4Ph-4}{κ2(N,O)}] (N,O = alanine (Pd-A), valine (Pd-V), leucine (Pd-L), l-isoleucine (Pd-I) and phenylalanine (Pd-F)) were prepared by cyclopalladation of the phosphorus ylide, bridge cleavage reaction and subsequent chelation of natural α-amino acids. The complexes were fully identified using IR and multinuclear 1H, 13C, 31P NMR spectroscopic methods. X-ray crystallography exhibited that the Pd(ii) atom is located in a slightly distorted square-planar environment surrounded by C,C-orthometallated phosphorus ylide as well as NO-pendant amino acid functionality. In vitro cytotoxicity evaluation of new cyclometallated Pd(ii) complexes toward a human leukemia (K562) cancer cell line indicated promising results. The highest cytotoxic activity was discovered in the case of phenylalanine (CH2C6H5). IC50 values of this complex on a panel of human tumor cell lines representative of liver (HepG2), breast (SKBR-3), and ovarian (A2780-Resistance/Sensitive) cancers also indicated promising antitumor effects in comparison with standard cisplatin. The binding interaction ability of the phenylalanine-containing orthopalladated complex, as the most efficient compound, with calf-thymus deoxyribonucleic acid (CT-DNA) and bovine serum albumin (BSA) was investigated. UV-Vis spectroscopy, competitive emission titration, and circular dichroism (CD) techniques demonstrated the intercalative binding of the Pd(ii) complex with DNA. Molecular docking studies also fully agreed with the experimental data. Examination of the reactivity towards the protein BSA revealed that the static quenching mechanism of BSA intrinsic fluorescence by the Pd(ii) complex with a binding constant (Kb) of ∼105 is indicative of the high affinity of the complex. The competitive binding experiment using site markers with definite binding sites demonstrated that the hydrophobic cavities of site I (subdomain IIA) are responsible for the bimolecular interaction between protein BSA and the complex. Molecular docking studies effectively confirmed the significance of hydrophobic interactions in Pd(ii)-BSA binding. The results of this study could greatly contribute to exploring new potent metal-based anticancer drugs.

Reactivity of [Pt(P t Bu3)2] with Zinc(I/II) Compounds: Bimetallic Adducts, Zn-Zn Bond Cleavage, and Cooperative Reactivity

Metal-only Lewis pairs (MOLPs) based on zinc electrophiles are particularly interesting due to their relevance to Negishi cross-coupling reactions. Zinc-based ligands in bimetallic complexes also render unique reactivity to the transition metals at which they are bound. Here we explore the use of sterically hindered [Pt(P t Bu3)2] (1) to access Pt/Zn bimetallic complexes. Compounds [(P t Bu3)2Pt → Zn(C6F5)2] (2) and [Pt(ZnCp*)6] (3) (Cp* = pentamethylcyclopentadienyl) were isolated by reactions with Zn(C6F5)2 and [Zn2Cp*2], respectively. We also disclose the cooperative reactivity of 1/ZnX2 pairs (X = Cl, Br, I, and OTf) toward water and dihydrogen, which can be understood in terms of bimetallic frustration.

Metal-only Lewis Pairs of Rhodium with s, p and d-Block Metals

Metal-only Lewis pairs (MOLPs) in which the two metal fragments are solely connected by a dative M→M bond represent privileged architectures to acquire fundamental understanding of bimetallic bonding. This has important implications in many catalytic processes or supramolecular systems that rely on synergistic effects between two metals. However, a systematic experimental/computational approach on a well-defined class of compounds is lacking. Here we report a family of MOLPs constructed around the RhI precursor [(η5 -C5 Me5 )Rh(PMe3 )2 ] (1) with a series of s, p and d-block metals, mostly from the main group elements, and investigate their bonding by computational means. Among the new MOLPs, we have structurally characterized those formed by dative bonding between 1 and MgMeBr, AlMe3 , GeCl2 , SnCl2 , ZnMe2 and Zn(C6 F5 )2, as well as spectroscopically identified the ones resulting from coordination to MBArF (M=Na, Li; BArF - =[B(C6 H2 -3,5-(CF3 )2 )4 ]- ) and CuCl. Some of these compounds represent unique examples of bimetallic structures, such as the first unambiguous cases of Rh→Mg dative bonding or base-free rhodium bound germylene and stannylene species. Multinuclear NMR spectroscopy, including 103 Rh NMR, is used to probe the formation of Rh→M bonds. A comprehensive theoretical analysis of those provides clear trends. As anticipated, greater bond covalency is found for the more electronegative acids, whereas ionic character dominates for the least electronegative nuclei, though some degree of electron sharing is identified in all cases.

Reversible Hydride Migration from C5Me5 to RhI Revealed by a Cooperative Bimetallic Approach

The use of cyclopentadienyl ligands in organometallic chemistry and catalysis is ubiquitous, mostly due to their robust spectator role. Nonetheless, increasing examples of non-innocent behaviour are being documented. Here, we provide evidence for reversible intramolecular C-H activation at one methyl terminus of C5Me5 in [(η-C5Me5)Rh(PMe3)2] to form a new Rh-H bond, a process so far restricted to early transition metals. Experimental evidence was acquired from bimetallic rhodium/gold structures in which the gold center binds either to the rhodium atom or to the activated Cp* ring. Reversibility of the C-H activation event regenerates the RhI and AuI monometallic precursors, whose cooperative reactivity towards polar E-H bonds (E=O, N), including the N-H bonds in ammonia, can be understood in terms of bimetallic frustration.

Cooperative activation of X-H (X = H, C, O, N) bonds by a Pt(0)/Ag(i) metal-only Lewis pair

Metal-only Lewis pairs made of Pt(0)/Ag(i) combinations have been previously reported, but their cooperative reactivity remains unexplored. Here we demonstrate that these systems are capable of synergistically activating a wide variety of X-H (X = H, C, O, N) bonds, including those in dihydrogen, alkynes, water and ammonia.

Cycloplatinated(ii) complexes bearing 1,1′-bis(diphenylphosphino)ferrocene ligand: biological evaluation and molecular docking studies

Cycloplatinated(ii) complexes containing dppf ligand were prepared. These complexes exhibited high cytotoxicity and apoptosis-inducing activities to human cancer cell lines.

Synthesis, structural characterization, biological evaluation and molecular docking studies of new platinum(ii) complexes containing isocyanides

Platinum(ii) complexes with various isocyanides are prepared and their biological activities are studied.